Esomeprazole

Introducing AIT Pharmaceuticals Division’s Esomeprazole Range

At AIT Pharmaceuticals Division, we are dedicated to advancing healthcare through the development of innovative pharmaceutical solutions. Our Esomeprazole Range is a testament to our commitment to providing effective treatments for gastrointestinal conditions. Esomeprazole, the active ingredient in our range, is a proton pump inhibitor (PPI) used in the management of acid-related disorders.

Share

Description

Drug Classification: Esomeprazole is classified as a proton pump inhibitor (PPI). It works by irreversibly inhibiting the proton pump in the gastric parietal cells, thereby reducing gastric acid secretion.

Formulations:

  • Esomeprazole Capsules: Available in strengths of 20mg and 40mg, our capsules provide convenient and precise dosing for patients.
  • Esomeprazole General Dry Powder Injection: Each vial contains 40mg of Esomeprazole for intravenous administration, offering rapid relief for patients unable to take oral medication.

Indications:

Esomeprazole is indicated for the:

  • Treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis.
  • Maintenance of healing of erosive esophagitis.
  • Treatment of duodenal ulcers and gastric ulcers.
  • Reduction of risk of gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs) in patients at risk.

Pharmacokinetics:

  • Absorption: Esomeprazole is rapidly absorbed after oral administration, with peak plasma concentrations achieved within 1-2 hours.
  • Distribution: It is extensively distributed throughout the body, including the gastrointestinal tract.
  • Metabolism: Esomeprazole undergoes hepatic metabolism via CYP2C19 and CYP3A4 enzymes.
  • Elimination: The elimination half-life of Esomeprazole is approximately 1-1.5 hours, with the majority of the drug excreted in the urine as metabolites.

Pharmacodynamics:

Esomeprazole inhibits the proton pump in the gastric parietal cells, resulting in a profound and prolonged suppression of gastric acid secretion. This mechanism of action provides effective relief from symptoms of acid-related disorders and promotes healing of damaged mucosa.

Usage:

  • Esomeprazole capsules should be taken orally, usually once daily, with or without food.
  • The general dry powder injection is administered intravenously over a period of 10-30 minutes, as directed by a healthcare professional.

Dosage:

  • The recommended dosage of Esomeprazole for adults varies depending on the indication and severity of the condition.
  • Common dosages include 20mg or 40mg once daily for the treatment of GERD and maintenance of healing of erosive esophagitis.

Side Effects:

  • Common side effects of Esomeprazole may include:
    • Headache
    • Nausea
    • Abdominal pain
    • Diarrhea
    • Flatulence
  • Serious side effects such as Clostridium difficile-associated diarrhea and hypomagnesemia may occur but are rare.

Experience the efficacy and reliability of AIT Pharmaceuticals Division’s Esomeprazole Range in the management of acid-related disorders. For more information, please contact us.

Reviews

There are no reviews yet.

Be the first to review “Esomeprazole”

Your email address will not be published. Required fields are marked *

Shopping Basket